The role played by PYCRs-mediated Proline synthesis in cancer progression is supported by unbiased transcriptomics, metabolomics, and proteomics studies, indicating that PYCRs expression levels, especially PYCR1, influence the clinical course of cancer (Table 1). This evidence concerns the gene PYCR1 and cancer.